Lazard Asset Management LLC Ptc Therapeutics, Inc. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 11,578 shares of PTCT stock, worth $576,468. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,578
Previous 18,660
37.95%
Holding current value
$576,468
Previous $570,000
24.74%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding PTCT
# of Institutions
231Shares Held
78.1MCall Options Held
144KPut Options Held
54.8K-
Vanguard Group Inc Valley Forge, PA9.13MShares$454 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$393 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$387 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$368 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$360 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.56B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...